These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


782 related items for PubMed ID: 11797012

  • 21. Vaccine-induced CD8+ T cells control AIDS virus replication.
    Mudd PA, Martins MA, Ericsen AJ, Tully DC, Power KA, Bean AT, Piaskowski SM, Duan L, Seese A, Gladden AD, Weisgrau KL, Furlott JR, Kim YI, Veloso de Santana MG, Rakasz E, Capuano S, Wilson NA, Bonaldo MC, Galler R, Allison DB, Piatak M, Haase AT, Lifson JD, Allen TM, Watkins DI.
    Nature; 2012 Nov 01; 491(7422):129-33. PubMed ID: 23023123
    [Abstract] [Full Text] [Related]

  • 22. Gag-specific cytotoxic T-lymphocyte-based control of primary simian immunodeficiency virus replication in a vaccine trial.
    Kawada M, Tsukamoto T, Yamamoto H, Iwamoto N, Kurihara K, Takeda A, Moriya C, Takeuchi H, Akari H, Matano T.
    J Virol; 2008 Oct 01; 82(20):10199-206. PubMed ID: 18667518
    [Abstract] [Full Text] [Related]

  • 23. Definition of human immunodeficiency virus type 1 gp120 and gp41 cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I alleles in simian-human immunodeficiency virus-infected rhesus monkeys.
    Voss G, Letvin NL.
    J Virol; 1996 Oct 01; 70(10):7335-40. PubMed ID: 8794394
    [Abstract] [Full Text] [Related]

  • 24. Trivalent live attenuated influenza-simian immunodeficiency virus vaccines: efficacy and evolution of cytotoxic T lymphocyte escape in macaques.
    Reece JC, Alcantara S, Gooneratne S, Jegaskanda S, Amaresena T, Fernandez CS, Laurie K, Hurt A, O'Connor SL, Harris M, Petravic J, Martyushev A, Grimm A, Davenport MP, Stambas J, De Rose R, Kent SJ.
    J Virol; 2013 Apr 01; 87(8):4146-60. PubMed ID: 23345519
    [Abstract] [Full Text] [Related]

  • 25. High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum.
    LaFranco-Scheuch L, Abel K, Makori N, Rothaeusler K, Miller CJ.
    J Virol; 2004 Jun 01; 78(12):6399-408. PubMed ID: 15163733
    [Abstract] [Full Text] [Related]

  • 26. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.
    Barouch DH, Powers J, Truitt DM, Kishko MG, Arthur JC, Peyerl FW, Kuroda MJ, Gorgone DA, Lifton MA, Lord CI, Hirsch VM, Montefiori DC, Carville A, Mansfield KG, Kunstman KJ, Wolinsky SM, Letvin NL.
    Nat Immunol; 2005 Mar 01; 6(3):247-52. PubMed ID: 15685174
    [Abstract] [Full Text] [Related]

  • 27. Linking pig-tailed macaque major histocompatibility complex class I haplotypes and cytotoxic T lymphocyte escape mutations in simian immunodeficiency virus infection.
    Gooneratne SL, Alinejad-Rokny H, Ebrahimi D, Bohn PS, Wiseman RW, O'Connor DH, Davenport MP, Kent SJ.
    J Virol; 2014 Dec 01; 88(24):14310-25. PubMed ID: 25275134
    [Abstract] [Full Text] [Related]

  • 28. Tat protein vaccination of cynomolgus macaques influences SHIV-89.6P cy243 epitope variability.
    Ridolfi B, Genovese D, Argentini C, Maggiorella MT, Sernicola L, Buttò S, Titti F, Borsetti A, Ensoli B.
    Virus Genes; 2008 Feb 01; 36(1):105-15. PubMed ID: 18049888
    [Abstract] [Full Text] [Related]

  • 29. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
    Friedrich TC, Dodds EJ, Yant LJ, Vojnov L, Rudersdorf R, Cullen C, Evans DT, Desrosiers RC, Mothé BR, Sidney J, Sette A, Kunstman K, Wolinsky S, Piatak M, Lifson J, Hughes AL, Wilson N, O'Connor DH, Watkins DI.
    Nat Med; 2004 Mar 01; 10(3):275-81. PubMed ID: 14966520
    [Abstract] [Full Text] [Related]

  • 30. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Barouch DH, Santra S, Schmitz JE, Kuroda MJ, Fu TM, Wagner W, Bilska M, Craiu A, Zheng XX, Krivulka GR, Beaudry K, Lifton MA, Nickerson CE, Trigona WL, Punt K, Freed DC, Guan L, Dubey S, Casimiro D, Simon A, Davies ME, Chastain M, Strom TB, Gelman RS, Montefiori DC, Lewis MG, Emini EA, Shiver JW, Letvin NL.
    Science; 2000 Oct 20; 290(5491):486-92. PubMed ID: 11039923
    [Abstract] [Full Text] [Related]

  • 31. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC, Dunham RM, Makedonas G, Vanderford TH, Sumpter B, Klatt NR, Ratcliffe SJ, Garg S, Paiardini M, McQuoid M, Altman JD, Staprans SI, Betts MR, Garber DA, Feinberg MB, Silvestri G.
    J Immunol; 2009 Jul 01; 183(1):706-17. PubMed ID: 19542473
    [Abstract] [Full Text] [Related]

  • 32. Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection.
    O'Connor D, Friedrich T, Hughes A, Allen TM, Watkins D.
    Immunol Rev; 2001 Oct 01; 183():115-26. PubMed ID: 11782252
    [Abstract] [Full Text] [Related]

  • 33. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW.
    J Virol; 2005 Oct 01; 79(19):12321-31. PubMed ID: 16160159
    [Abstract] [Full Text] [Related]

  • 34. Use of major histocompatibility complex class I/peptide/beta2M tetramers to quantitate CD8(+) cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Egan MA, Kuroda MJ, Voss G, Schmitz JE, Charini WA, Lord CI, Forman MA, Letvin NL.
    J Virol; 1999 Jul 01; 73(7):5466-72. PubMed ID: 10364294
    [Abstract] [Full Text] [Related]

  • 35. Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development?
    O'Connor D, Allen T, Watkins DI.
    Immunol Lett; 2001 Nov 01; 79(1-2):77-84. PubMed ID: 11595292
    [Abstract] [Full Text] [Related]

  • 36. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?
    Vogel TU, Friedrich TC, O'Connor DH, Rehrauer W, Dodds EJ, Hickman H, Hildebrand W, Sidney J, Sette A, Hughes A, Horton H, Vielhuber K, Rudersdorf R, De Souza IP, Reynolds MR, Allen TM, Wilson N, Watkins DI.
    J Virol; 2002 Nov 01; 76(22):11623-36. PubMed ID: 12388723
    [Abstract] [Full Text] [Related]

  • 37. Structural constraints on viral escape from HIV- and SIV-specific cytotoxic T-lymphocytes.
    Peyerl FW, Barouch DH, Letvin NL.
    Viral Immunol; 2004 Nov 01; 17(2):144-51. PubMed ID: 15279695
    [Abstract] [Full Text] [Related]

  • 38. Cytotoxic T lymphocytes do not appear to select for mutations in an immunodominant epitope of simian immunodeficiency virus gag.
    Chen ZW, Shen L, Miller MD, Ghim SH, Hughes AL, Letvin NL.
    J Immunol; 1992 Dec 15; 149(12):4060-6. PubMed ID: 1460291
    [Abstract] [Full Text] [Related]

  • 39. Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts.
    Friedrich TC, McDermott AB, Reynolds MR, Piaskowski S, Fuenger S, De Souza IP, Rudersdorf R, Cullen C, Yant LJ, Vojnov L, Stephany J, Martin S, O'Connor DH, Wilson N, Watkins DI.
    J Virol; 2004 Sep 15; 78(18):10064-73. PubMed ID: 15331739
    [Abstract] [Full Text] [Related]

  • 40. Identification of a cytotoxic T-lymphocyte (CTL) epitope recognized by Gag-specific CTLs in cynomolgus monkeys infected with simian/human immunodeficiency virus.
    Negri DRM, Borghi M, Baroncelli S, Macchia I, Buffa V, Sernicola L, Leone P, Titti F, Cara A.
    J Gen Virol; 2006 Nov 15; 87(Pt 11):3385-3392. PubMed ID: 17030874
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 40.